Oppenheimer Asset Management Inc. Purchases New Stake in Privia Health Group, Inc. $PRVA
Oppenheimer Asset Management Inc. acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 226,999 shares of the company's
Oppenheimer Asset Management Inc. acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA-Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 226,999 shares of the company's stock, valued at approximately $5,841,000. Oppenheimer Asset Management Inc. owned approximately 0. 18% of Privia Health Group as of its most recent filing with the Securities & Exchange Commission. GetPrivia Health Groupalerts:A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Durable Capital Partners LP increased its stake in shares of Privia Health Group by 1. 8% in the 3rd quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company's stock worth $291,123,000 after acquiring an additional 203,842 shares during the last quarter. State Street Corp boosted its position in shares of Privia Health Group by 1. 5% during the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company's stock valued at $95,935,000 after acquiring an additional 61,853 shares during the last quarter. Van Berkom & Associates Inc. boosted its position in shares of Privia Health Group by 5. 4% during the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company's stock valued at $83,371,000 after acquiring an additional 208,787 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Privia Health Group by 1. 1% in the fourth quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company's stock valued at $66,738,000 after purchasing an additional 31,204 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in shares of Privia Health Group by 1. 6% in the fourth quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company's stock valued at $66,099,000 after purchasing an additional 43,589 shares during the period. Institutional investors and hedge funds own 94. 48% of the company's stock. Wall Street Analyst Weigh InA number of brokerages have commented on PRVA. Barclays reduced their target price on shares of Privia Health Group from $25. 00 to $24. 00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 26th. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 5th. Canaccord Genuity Group set a $32. 00 price target on shares of Privia Health Group in a report on Friday, August 7th. Citigroup reaffirmed a "buy" rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Finally,Weiss Ratingsupgraded Privia Health Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, July 2nd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat. com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $31. 00. Check Out Our Latest Research Report on Privia Health GroupPrivia Health Group Price PerformanceShares ofPrivia Health Group stockopened at $22. 00 on Friday. The business has a 50-day moving average of $24. 71 and a 200 day moving average of $23. 29. Privia Health Group, Inc. has a 12 month low of $19. 53 and a 12 month high of $28. 82. The stock has a market capitalization of $2. 81 billion, a price-to-earnings ratio of 104. 77, a price-to-earnings-growth ratio of 1. 77 and a beta of 0. 85. Insider ActivityIn other news, CFODavid Mountcastlesold 21,275 shares of the stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $27. 67, for a total transaction of $588,679. 25. Following the sale, the chief financial officer owned 164,853 shares of the company's stock, valued at approximately $4,561,482. 51. This represents a 11. 43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed throughthe SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, DirectorMatthew Shawn Morrissold 53,722 shares of the firm's stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $27. 24, for a total transaction of $1,463,387. 28. Following the completion of the transaction, the director directly owned 68,188 shares of the company's stock, valued at approximately $1,857,441. 12. The trade was a 44. 07% decrease in their position. Additional details regarding this sale are available in theofficial SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 327,886 shares of company stock worth $8,628,256 in the last three months. Corporate insiders own 5. 70% of the company's stock. Privia Health Group Profile(Free Report)Privia Health GroupNASDAQ: PRVAis a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models. Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States. See AlsoFive stocks we like better than Privia Health GroupIs Best Buy the AI Winner Hiding in the Electronics Aisle?Applied Materials Beat Everything but Wall Street’s Expectations for MarginsBack From Orbit, Intuitive Machines' Share Price Enters the Buy ZoneTexas Roadhouse and Brinker International Have the Recipe Rivals Are MissingThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Privia Health Group Right Now?Before you consider Privia Health Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Privia Health Group wasn't on the list. While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free Report